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Michael D. Ober, MD, FACS a,b,⇑AbstractPurpose: To report four cases of premacular hemorrhage secondary to valsalva retinopathy treated with Nd:YAG membranotomy
and discuss techniques as well as the literature.
Design: Retrospective case series.
Methods: A retrospective review was conducted for four patients with vision obstructing hemorrhage secondary to valsalva
retinopathy. These patients were all treated with Nd:YAG membranotomy.
Results: Four patients with premacular hemorrhage secondary to valsalva retinopathy were treated with Nd:YAG laser creating a
membranotomy to drain the hemorrhage. Power settings ranged from 1.7 to 3.8 mJ. Visual acuity at presentation ranged from 20/
400 (1 patient) to count fingers (3 patients). Visual acuity improved in three out of four patients after laser treatment. Final visual
acuity ranged from 20/20 to 20/30 in these three patients. One patient was lost to follow up after performing laser membranotomy
and therefore visual acuity after treatment was not obtained. No complications were noted.
Conclusion: Nd:YAG membranotomy is a non-invasive, office-based treatment option that may be successfully used to treat
premacular hemorrhage secondary to valsalva retinopathy.
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Premacular hemorrhage is a rare source of painless loss
of vision. Causes include valsalva retinopathy,1–8 prolifera-
tive diabetic retinopathy,9–11 vein occlusion,1 macroaneu-
rysm,11–16 hematologic disorders17,18 and trauma1,19
among others.7,20 The typical funduscopic appearance is
that of a well-circumscribed hemorrhage at the vitreoretinal
interface. The blood is believed to accumulate in the
potential space under the internal limiting membrane (ILM)
especially for valsalva related instances,3,6,21 or between
the ILM and hyaloid face.
Management options include observation, Neodym-
ium:YAG laser (Nd:YAG) membranotomy and pars plana
vitrectomy. Spontaneous resolution can take several weeksor months depending on the thickness and total amount of
blood present. The prolonged presence of sub-ILM blood
may lead to the development of significant epiretinal tissue
proliferation.8 While pars plana vitrectomy likely has the
greatest anatomic success rate, the well-known complica-
tions limit immediate use in the majority of situations.7
Nd:YAG hyaloidotomy has been reported to be a relatively
safe and effective method of draining premacular hemor-
rhage into the vitreous cavity.1–3,5,7,8,10,11,14,19,22–26 In this
report, we describe several cases of successful use of
Nd:YAG laser in the treatment of premacular hemorrhage
due to valsalva retinopathy as well as a discussion of the
literature and techniques.e:
al.com
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Patient records were reviewed from 1 private retina
practice (Retina Consultants of Michigan) and 1 academic
retina practice (Henry Ford Health Systems) for those with
vision loss secondary to premacular hemorrhage associated
with valsalva retinopathy between 2007 and 2011. Four total
records were obtained and analyzed. For the discussion, an
online PubMed literature search was conducted using
keywords, ‘‘valsalva retinopathy’’, ‘‘preretinal hemorrhage’’,
and ‘‘YAG.’’ Additional sources were obtained for the discus-
sion from the references within the articles obtained. The
Institutional Review Board from Henry Ford Health Systems
approved this study and the authors adhered to the
principles of the Declaration of Helsinki for clinical research.Figure 2. (A) Color fundus photograph three years after successful
Nd:YAG hyaloidotomy of the patient in Case 1, there is wrinkling of
posterior hyaloid. (B) Corresponding vertical optical coherence
tomography scan shows the detached internal limiting membrane
(attached to posterior hyaloid) with an opening secondary to Nd:YAG
membranotomy without underlying retinal damage.Description of cases
Case 1
A 26 year-old female presented with complaints of sudden
painless vision loss in her right eye following an episode of
emesis three days prior. She had no past ocular history. Her
past medical history was significant for rheumatoid arthritis
and medications were plaquenil, daypro, azulfidine, venlafax-
ine and birth control pills. On examination, her visual acuity
was 20/400 OD eccentrically and 20/20 OS. Intraocular pres-
sures and anterior chamber examination were normal bilater-
ally. Dilated fundus examination of the right eye showed a
large subhyaloid hemorrhage covering most of the macula
including the fovea (Fig. 1 A).
Nd:YAG was applied in single shots to the hyaloid face
beginning at 1.7 mJ without appreciable effect. The laser
power was titrated through 2.9 mJ without effect. Finally, a
single shot at 3.8 mJ led to successful photodisruption. The
majority of blood immediately drained into the inferior vitre-
ous (Fig. 1 B) with near complete recovery of vision.
Three days after the procedure, the vision in her right eye
was 20/25. Dilated fundus examination showed inferior
vitreous hemorrhage with complete clearing in front of theFigure 1. (A) Montage color fundus photograph from case 1 demonstratin
(B) Color montage following Neodymium:YAG (Nd:YAG) hyaloidotomy, the hmacula. One month later, she was 20/25+ with further clear-
ing of vitreous hemorrhage. The retina remained flat and no
complications were encountered. Three years after her
initial presentation, vision improved further to 20/20 andg a boat-shaped premacular hemorrhage due to valsalva retinopathy.
emorrhage drains inferiorly into vitreous.
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macula without evidence of epiretinal membrane or subreti-
nal fibrosis (Fig. 2A and B).Case 2
A 35 year-old woman who was 35 weeks pregnant with
twins presented with a 10 day history of sudden painless
loss of vision in her right eye which developed after a pro-
longed episode of sneezing and coughing. Her past ocular
history was significant for photorefractive keratectomy
11 years prior. Her past medical history was significant for a
normal pregnancy and upper respiratory infection. Prenatal
vitamins were her only medication.
On examination, her corrected visual acuity was counting
fingers OD and 20/30-OS. Anterior segment examination
was unremarkable bilaterally. Dilated fundus exam of the
right eye showed a boat-shaped preretinal hemorrhage
covering the macula as well as a larger area of subretinal
hemorrhage along the superotemporal arcade (Fig. 3A).
Due to the premacular hemorrhage, it was not possible to
determine if subretinal hemorrhage extended under the
central macula. OCT showed dense preretinal hemorrhage
leading to shadowing which precluded analysis of the
subretinal space (Fig. 3D). Dense subretinal fluid can be seen
adjacent to the area not obscured by the shadow effect.Figure 3. (A) Color fundus montage photograph of case 2 showing prem
superotemporal arcade. (B) Color fundus montage immediately following Nd:
color fundus photograph shows that the fovea is uncovered and the subretin
effect of the preretinal hemorrhage obstructing the image of the underlyingNd:YAG photodisruption was applied. Initial settings were
single shot at 2.5 mJ power without effect. Power was then
titrated to 3.4 mJ, after which a single shot caused the de-
sired membranotomy. Immediate drainage of the blood into
the inferior vitreous cavity was noted (Fig. 3B). The subretinal
hemorrhage along the superotemporal arcades did not
extend into the macula and did not appear to descend after
deflation of the sub-ILM fluid pocket. Three days later, visual
acuity in the right eye improved to 20/25+. Fundus examina-
tion showed that the premacular hemorrhage had almost
completely resolved and subretinal hemorrhage along the
superotemporal arcade appeared stable (Fig. 3C).
Case 3
A 31 year-old female presented to a general ophthalmolo-
gist complaining of sudden onset of painless loss of vision in
her left eye after an episode of emesis earlier that day. Her
past ocular and medical histories were unremarkable and
she took no medications. Visual acuity was 20/20 OD and
counting fingers OS. Dilated fundus examination of the left
eye revealed a well-circumscribed preretinal hemorrhage in
the macula with intraretinal hemorrhages along the supero-
temporal arcade (Fig. 4A). The patient was lost to follow-up
for 3 weeks when return visit showed that visual acuity OS
remained counting fingers. Dilated examination showed fibri-
noid debris above partially dehemoglobinized blood in theacular hemorrhage and a larger area of subretinal hemorrhage along
YAG membranotomy with active drainage of blood. (C) Three days later,
al blood appears stable. (D) Corresponding vertical OCT shows shadow
retina and subretinal space.
Figure 4. (A) Color fundus photograph of case 3 showing a well-circumscribed premacular hemorrhage with intraretinal hemorrhages along the
superotemporal arcade and along the peripheral border of the pre-retinal blood. (B) Color fundus photograph 3 weeks later demonstrating the blood
dehemoglobinized and clotted. (C and D) Color fundus photograph immediately after Nd:YAG membranotomy shows blood flowing through
membranotomy site, but drainage was minimal due to coagulation.
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membranotomy in the posterior hyaloid was performed using
the Nd:YAG laser (Fig. 4C and D). Most of the hemorrhage
however remained intact in a large clot and did not drain.
The patient was subsequently lost to follow up.Case 4
A 17 year-old female presented with complaints of sudden
painless loss of vision in her left eye for 1 day. She had no
pertinent past medical history and was not taking medica-
tion. Her visual acuity was 20/30 OD and counting fingers
OS. Fundus examination of the left eye showed a well-circum-
scribed pre-retinal hemorrhage obstructing the fovea (Fig. 5).
Fluorescein angiography showed central blocking without
evidence of leakage or other vascular abnormalities in the
fundus.
Given the classic clinical appearance, a diagnosis of val-
salva retinopathy was made. The patient and her parents
elected to observe initially. The patient returned after
6 weeks when her vision remained counting fingers and
posterior segment examination showed persistent hemor-
rhage obscuring the central macula (Fig. 5A). Nd:YAG was
applied to the inferior portion of the hemorrhage with 2 shots
at 2.5 mJ (Fig. 5 B). One day after the procedure, the patientnoted significant visual improvement and 6 weeks later
visual acuity measured 20/30. Four month follow up
showed that the vision improved to 20/30+ with early
wrinkling of the elevated ILM (Fig. 5 C). No complications
were encountered.Discussion
Nd:YAG membranotomy was first described by Faulborn
in 1988 to drain premacular subhyaloid hemorrhage into
the vitreous cavity.27 Since, there have been many case re-
ports and series in the literature describing similar Nd:YAG
membranotomy, with energy levels ranging from 2.5 to
50 mJ, with relatively good success.1–4,6,7,11,14,25–29
Premacular hemorrhage may lead to sudden vision loss
due to a number of underlying etiologies. In valsalva retinop-
athy, the increase in venous pressure is theorized to rupture
smaller capillaries in the superficial retina30 resulting in sub-
ILM hemorrhage or bleeding into the subhyaloid space.
Spontaneous resolution of premacular hemorrhage is
possible but absorption may take many months.31 During this
period, intraretinal tissue migration and proliferation may
lead to permanent structural damage. Pathological speci-
mens have shown tissues more similar to proliferative
vitreoretinopathy than idiopathic epiretinal membranes
Figure 5. (A) Montage color photograph of case 4 demonstrating dense premacular hemorrhage. (B) Color montage photograph shows successful
Nd:YAG membranotomy performed 6 weeks following initial presentation. (C) Color fundus photograph 4 months after Nd:YAG membranotomy shows
complete resolution of hemorrhage with early wrinkling of the ILM.
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(RPE) cells within the retina underneath the ILM.3 Further-
more, longstanding vitreous hemorrhage is felt to predispose
to fibrovascular tissue contraction. In cases of hemorrhage
besides valsalva, early treatment may allow for more rapid
visualization and treatment of underlying pathology.7 This
suggests that early removal of the blood with laser or vitrec-
tomy may be warranted for reasons other than early visual
recovery.7,8,31,32
The timing for treatment is critical, as successful displace-
ment of hemorrhage is dependent on its ability to flow
through the membranotomy by remaining liquid. As with
previous publications,7,32,33 our case 3 demonstrates that
pre-retinal hemorrhage may clot leading to failure of Nd:YAG
displacement despite successful creation of an opening in the
hyaloid/ILM. Case four shows that under certain
circumstances, even 6 weeks after initial hemorrhage, the
blood can remain liquid enough to drain fully following
Nd:YAG membranotomy. Once blood has clotted,
vitrectomy with manual blood removal would likely be
required for early visual recovery. However, in theory,
intravitreal injection of tissue plasminogen activator (TPA)
may liquefy the hemorrhage well enough to allow
subsequent laser displacement. While we were unable to finda publication describing this technique, TPA has been
successfully used along with intraocular air injection for
clotted premacular hemorrhage secondary to diabetic
retinopathy.9
Ulbig et al. described a case series of 21 patients who
underwent Nd:YAG laser treatment for premacular
hemorrhage. Most eyes demonstrated good visualization of
the macula within one month. Those patients with premacular
hemorrhage from valsalva or Terson’s syndrome demon-
strated best results.7 Complications up to six months after
laser treatment were negligible with only one retinal detach-
ment in a myopic patient with bilateral breaks and a single
additional eye that developed a macular hole. In the latter
patient, the photodisruptive effect may have been too near
the macula. Khan et al. reported no ocular complications
for 11 patients after laser membranotomy at 6 month fol-
low-up.2 In a case series published by Gabel et al., energy
levels up to 50 mJ were used with no retinal injury. The
preretinal blood is thought to provide a buffer that protects
the underlying retina from the laser energy.28 Sabella et al.
identified the location of the laser photodisruption on spec-
tral domain OCT and concluded that there was no damage
to the underlying retina. We were also able to identify the
ILM/hyaloid defect with spectral domain OCT (Fig. 2) and
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our case, the defect is close to the border of the ILM dis-
placement where traction on the surface ILM led to structural
changes unrelated to photodisruption. This tractional phe-
nomenon is noted at the border of the ILM detachment at
many sites prior to and after photodisruption in our case
and can be found in previously published cases.4,29
Epiretinal membrane (ERM) and contraction of the ILM are
known to occur following laser disruption of premacular hem-
orrhage. Kwok et al. analyzed one such membrane subse-
quently removed surgically and found hemosiderin deposits
under the contracted ILM with fine glial ERM on the outer
surface.3 It is likely this type of membrane is not laser in-
duced, but rather a secondary effect of hemorrhagic dis-
placement of the ILM. Case 1 also demonstrates one such
membrane (Fig. 2) that remained asymptomatic. OCT dem-
onstrates that the membrane in this case is detached from
the retina surface likely minimizing symptoms for the time
being.
Due to potential retinal damage, it has been advocated
that Nd:YAG therapy only be considered in premacular hem-
orrhages of at least 3 disc diameters in size. This helps to in-
crease the cushion effect of the hemorrhage in order to avoid
inadvertent retinal damage by the photodisruptive laser.7 In
our opinion, there are several important criteria to safely de-
liver Nd:YAG to the ILM/hyaloid face in valsalva retinopathy.
First is to choose the most appropriate location. Liquid hem-
orrhage will drain by gravity; therefore, the easiest location to
rapidly empty the trapped blood is to create a hole at the
inferior aspect of the fluid pocket. That being said, a buffer
is necessary between the laser spot and the underlying retina
to protect the retina from the forthcoming shockwave. There-
fore, a region distant enough from the inferior border where
there is significant hemorrhagic elevation is required. Fur-
thermore, a location away from the fovea is also prudent
which can create difficulty when the inferior position of the
hemorrhage is over the fovea. Depending on the configura-
tion and location of the hemorrhage, it may at times be safer
and therefore preferable to apply the laser to a lateral aspect
of the hemorrhage and then use head positioning to drain
the blood into the vitreous cavity. Case 2 demonstrates laser
membranotomy on the nasal aspect of the hemorrhage in or-
der to avoid the fovea (Fig. 3B), which required left sided
head positioning to drain the maximum amount of blood.
Next, the power settings certainly vary for individual situa-
tions. Common sense dictates that it is best to use the least
amount of power to create an adequate opening. We
suggest beginning with 2.0–2.5 mJ for situations with clear
media and titrating upwards as required. Puthalath et al.25
described using ‘‘stretch burns’’ to the hyaloid prior to a
penetrating photodisruption; however, we did not find that
step necessary in our cases. Media opacities such as cataract,
posterior capsular opacity, and vitreous hemorrhage will
significantly alter the required power settings. The choice
of lens is also individual. The Area Centralis (Volk Optical,
Inc; Mentor, OH) was used for cases 1–2 while a plano
macular contact lens was used for cases 3–4.
In this series, we described the successful use of the
Nd:YAG laser to drain three out of four acute cases of prem-
acular hemorrhage due to valsalva retinopathy. One case had
partial drainage due to delayed treatment and clotting of
subhyaloid blood. Nd:YAG laser treatment offers a simple,relatively safe, non-invasive treatment option for drainage
of premacular hemorrhage.Conflict of interest
The authors declared that there is no conflict of interest.References
1. Celebi S, Kukner AS. Photodisruptive Nd:YAG laser in the
management of premacular subhyaloid hemorrhage. Eur J
Ophthalmol 2001;11(3):281–6.
2. Khan MT, Saeed MU, Shehzad MS, Qazi ZA. Nd:YAG laser treatment
for valsalva premacular hemorrhages: 6 month follow up: alternative
management options for preretinal premacular hemorrhages in
Valsalva retinopathy. Int Ophthalmol 2008;28(5):325–7.
3. Kwok AK, Lai TY, Chan NR. Epiretinal membrane formation with
internal limiting membrane wrinkling after Nd:YAG laser
membranotomy in valsalva retinopathy. Am J Ophthalmol
2003;136(4):763–6.
4. Meyer CH, Mennel S, Rodrigues EB, Schmidt JC. Persistent
premacular cavity after membranotomy in valsalva retinopathy
evident by optical coherence tomography. Retina 2006;26(1):116–8.
5. Perez-Rico C, Montes-Mollon A, Castro-Rebollo M, et al. Optical
coherence tomography features of sub-internal limiting membrane
hemorrhage and temporary premacular cavity following Nd-YAG
laser membranotomy in valsalva retinopathy. Jpn J Ophthalmol
2008;52(6):513–5.
6. Shukla D, Naresh KB, Kim R. Optical coherence tomography findings
in valsalva retinopathy. Am J Ophthalmol 2005;140(1):134–6.
7. Ulbig MW, Mangouritsas G, Rothbacher HH, et al. Long-term results
after drainage of premacular subhyaloid hemorrhage into the
vitreous with a pulsed Nd:YAG laser. Arch Ophthalmol
1998;116(11):1465–9.
8. Gibran SK, Kenawy N, Wong D, Hiscott P. Changes in the retinal inner
limiting membrane associated with Valsalva retinopathy. Br J
Ophthalmol 2007;91(5):701–2.
9. Chung J, Park YH, Lee YC. The effect of Nd:YAG laser
membranotomy and intravitreal tissue plasminogen activator with
gas on massive diabetic premacular hemorrhage. Ophthalmic Surg
Lasers Imaging 2008;39(2):114–20.
10. Ezra E, Dowler JG, Burgess F, et al. Identifying maculopathy after
neodymium: YAG membranotomy for dense diabetic premacular
hemorrhage. Ophthalmology 1996;103(10):1568–74.
11. Raymond LA. Neodymium:YAG laser treatment for hemorrhages
under the internal limiting membrane and posterior hyaloid face in
the macula. Ophthalmology 1995;102(3):406–11.
12. Zhao P, Hayashi H, Oshima K, et al. Vitrectomy for macular
hemorrhage associated with retinal arterial macroaneurysm.
Ophthalmology 2000;107(3):613–7.
13. Dahreddine M, Eldirani H, Mutsinzi E, Hirsch A. Retinal arterial
macroaneurysm complicated by premacular hemorrhage: treatment
by YAG laser disruption. J Fr Ophtalmol 2011;34(2):131e1–5.
14. Dori D, Gelfand Y, Erlik N, Miller B. Nd:YAG laser treatment for
premacular hemorrhage. Ophthalmic Surg Lasers
1998;29(12):998–1000.
15. Iijima H, Satoh S, Tsukahara S. Nd:YAG laser photodisruption for
preretinal hemorrhage due to retinal macroaneurysm. Retina
1998;18(5):430–4.
16. Tassignon MJ, Stempels N, Van Mulders L. Retrohyaloid premacular
hemorrhage treated by Q-switched Nd-YAG laser. A case report.
Graefes Arch Clin Exp Ophthalmol 1989;227(5):440–2.
17. Hlozanek M, Dotrelova D, Vrabcova TL, Osmera J. Nd:YAG laser
membranotomy treatment of premacular hemorrhage in two children
with hematologic disease. Eur J Ophthalmol 2006;16(3):478–80.
18. Khadka D, Sharma AK, Shrestha JK, et al. Nd:Yag laser treatment for
sub-hyaloid hemorrhage in childhood acute leukemia. Nepal J
Ophthalmol 2012;4(1):102–7.
19. Aralikatti AK, Haridas AS, Smith JM. Delayed Nd:YAG laser
membranotomy for traumatic premacular hemorrhage. Arch
Ophthalmol 2006;124(10):1503.
Nd:YAG membranotomy for preretinal hemorrhage secondary to valsalva retinopathy 15120. Monshizadeh R, Tariq Bhatti M, Levine L, Tabandeh H.
Photodisruption of dense preretinal hemorrhage with Nd:YAG in a
child with Terson’s syndrome. J AAPOS 2002;6(1):56–8.
21. Meyer CH, Mennel S, Rodrigues EB, Schmidt JC. Is the location of
valsalva hemorrhages submembranous or subhyaloidal? Am J
Ophthalmol 2006;141(1):231.
22. Abouzeid H, Wolfensberger TJ. Nd:YAG laser for treatment of
premacular subhyaloid hemorrhage. Klin Monbl Augenheilkd
2011;228(4):389–90.
23. Adel B, Israel A, Friedman Z. Dense subhyaloid hemorrhage or
subinternal limiting membrane hemorrhage in the macula treated by
Nd:YAG laser. Arch Ophthalmol 1998;116(11):1542–3.
24. Kaynak S, Eryildirim A, Kaynak T, et al. Nd:YAG laser posterior
hyaloidotomy in subhyaloid hemorrhage. Ophthalmic Surg
1994;25(7):474–6.
25. Puthalath S, Chirayath A, Shermila MV, et al. Frequency-doubled
Nd:YAG laser treatment for premacular hemorrhage. Ophthalmic
Surg Lasers Imaging 2003;34(4):284–90.
26. Zaman F, Irwin R, Godley BF. Nd:YAG laser treatment for macular
preretinal hemorrhage. Arch Ophthalmol 1999;117(5):694–5.27. Faulborn J. Behandlung einer diabetischen praemaculaeren Blutung
mit dem Oswitched Neodym:YAG laser. Spektrum Augenheilkd
1988;2:33–5.
28. Gabel VP, Birngruber R, Gunther-Koszka H, Puliafito CA. Nd:YAG
laser photodisruption of hemorrhagic detachment of the internal
limiting membrane. Am J Ophthalmol 1989;107(1):33–7.
29. Sabella P, Bottoni F, Staurenghi G. Spectral-domain OCT evaluation
of Nd:YAG laser treatment for Valsalva retinopathy. Graefes Arch
Clin Exp Ophthalmol 2010;248(4):599–601.
30. Duane TD. Valsalva hemorrhagic retinopathy. Am J Ophthalmol
1973;75(4):637–42.
31. O’Hanley GP, Canny CL. Diabetic dense premacular hemorrhage. A
possible indication for prompt vitrectomy. Ophthalmology
1985;92(4):507–11.
32. Mansour A. Nd:YAG laser photodisruption of hemorrhagic
detachment of the internal limiting membrane. Am J Ophthalmol
1989;107(5):566–8.
33. Cheung CM, Benson MT. Post-chemotherapy premacular subhyaloid
haemorrhage. Eye (Lond) 2003;17(1):97–9, author reply 114.
